Description: NIOX Group Plc, a diagnostics and management company, provides point-of-care fractional exhaled nitric oxide (FeNo) diagnosis and management products worldwide. Its products include NIOX VERO, a portable system for the non-invasive measurement of nitric oxide in human breath. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.
Home Page: investors.niox.com
NIOX Technical Analysis
Hayakawa Building
Oxford,
OX4 4GB
United Kingdom
Phone:
44 3303 309 356
Officers
| Name | Title |
|---|---|
| Mr. Ian Roy Johnson | Executive Chairman |
| Mr. Michael Roy David Roller A.C.A., BA (Hons) | CFO & Director |
| Mr. Jonathan Emms | COO & Executive Director |
| Ms. Nina Kataria | Senior Vice President Global Human Resources |
| Mr. Tom Scaccia | Senior Vice President of Americas & Research Business |
| Ms. Sarah Elizabeth Duncan | Company Secretary |
Exchange: LSE
Country: UK : United Kingdom
Currency: Pence sterling (p)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 57.4713 |
|---|---|
| Trailing PE: | 31.3 |
| Price-to-Book MRQ: | 3.2561 |
| Price-to-Sales TTM: | 6.8078 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 92 |